Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David James Ballance currently holds 8,519 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David James Ballance has been a net buyer of PHAS stock. They have purchased $3.9K and sold $0 worth of shares.
David James Ballance's most recent insider trade was on Nov 20, 2020, when they sold 919 shares at $3.00 per share.
David James Ballance serves as Executive at PhaseBio Pharmaceuticals Inc (PHAS). They have executed 2 insider transactions totaling $3.9K over their tenure at the company.
David James Ballance holds the position of Executive at PhaseBio Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
David James Ballance has shown a buying trading pattern, with $3.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David James Ballance was on Dec 13, 2018, when they purchased $3.9K worth of PHAS shares. This transaction involved 1,000 shares at $3.94 per share.
David James Ballance currently owns 8,519 shares of PhaseBio Pharmaceuticals Inc (PHAS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David James Ballance's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David James Ballance has 2 Form 4 filings on record as an insider at PhaseBio Pharmaceuticals Inc.
Set alerts for David James Ballance and 40,000+ other insiders.